Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability comparison of etoricoxib 120 mg tablets from Spain vs USA manufacturing sites
NL-OMON37397Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of etoricoxib in osteoarthritis (OA) and rheumatism (2 arms), sponsored by Merck & Co. Primary endpoint: Relative bioavailability of etoricoxib 120 mg tablets manufactured at Frosst Iberica, Spain and Elkton, VA, USA. Started Feb 2012; status: active, not recruiting.
02
Drugs
etoricoxib
03
Conditions
osteoarthritis (OA)rheumatism
Beyond the preview
Go deeper on NL-OMON37397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37397.